Open AccessResults of a randomized and controlled clinical trial evaluating the efficacy and safety of combination therapy with Endostar and S-1 combined with oxaliplatin in advanced gastric cancer
Author(s) -
Jiang Liu,
Xu,
Ma,
Mayier,
Su,
Naman,
Jieensi,
Yang Yang,
Adili,
Aili,
Wang,
Chen,
Kebinu,
Han,
Ayixiamu
Publication year - 2013
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s46487
Subject(s) - medicine , oxaliplatin , adverse effect , randomized controlled trial , cancer , oncology , endostatin , gastroenterology , clinical trial , colorectal cancer , vegf receptors
We aimed to evaluate the efficacy and safety of combination therapy of Endostar (recombinant human endostatin) and S-1 combined with oxaliplatin (SOX) in patients with advanced gastric cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom